<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(59)</volume><submitter>Zhao F</submitter><pubmed_abstract>Chemodynamic therapy (CDT) is a booming technology that utilizes Fenton reagents to kill tumor cells by transforming intracellular H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> into reactive oxygen species (ROS), but insufficient endogenous H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> makes it difficult to attain satisfactory antitumor results. In this article, a H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>-free CDT technique with tumor-specificity is developed by using pH-sensitive magnetic iron carbide nanoparticles (PEG/Fe&lt;sub>2&lt;/sub>C@Fe&lt;sub>3&lt;/sub>O&lt;sub>4&lt;/sub> NPs) to trigger artemisinin (ART) to &lt;i>in situ&lt;/i> form ROS. ART-loaded PEG/Fe&lt;sub>2&lt;/sub>C@Fe&lt;sub>3&lt;/sub>O&lt;sub>4&lt;/sub> NPs are fabricated for the enormous release of Fe&lt;sup>2+&lt;/sup> ions induced by the acidic conditions of the tumor microenvironment after magnetic-assisted tumor </pubmed_abstract><journal>RSC advances</journal><pagination>37504-37513</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9043768</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>-independent chemodynamic therapy initiated from magnetic iron carbide nanoparticle-assisted artemisinin synergy.</pubmed_title><pmcid>PMC9043768</pmcid><pubmed_authors>Su D</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Zheng J</pubmed_authors><pubmed_authors>Che S</pubmed_authors><pubmed_authors>Ying Y</pubmed_authors><pubmed_authors>Zhao F</pubmed_authors><pubmed_authors>Liang L</pubmed_authors><pubmed_authors>Gao W</pubmed_authors><pubmed_authors>Mou X</pubmed_authors><pubmed_authors>Qiao L</pubmed_authors><pubmed_authors>Cai W</pubmed_authors></additional><is_claimable>false</is_claimable><name>H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>-independent chemodynamic therapy initiated from magnetic iron carbide nanoparticle-assisted artemisinin synergy.</name><description>Chemodynamic therapy (CDT) is a booming technology that utilizes Fenton reagents to kill tumor cells by transforming intracellular H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> into reactive oxygen species (ROS), but insufficient endogenous H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> makes it difficult to attain satisfactory antitumor results. In this article, a H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>-free CDT technique with tumor-specificity is developed by using pH-sensitive magnetic iron carbide nanoparticles (PEG/Fe&lt;sub>2&lt;/sub>C@Fe&lt;sub>3&lt;/sub>O&lt;sub>4&lt;/sub> NPs) to trigger artemisinin (ART) to &lt;i>in situ&lt;/i> form ROS. ART-loaded PEG/Fe&lt;sub>2&lt;/sub>C@Fe&lt;sub>3&lt;/sub>O&lt;sub>4&lt;/sub> NPs are fabricated for the enormous release of Fe&lt;sup>2+&lt;/sup> ions induced by the acidic conditions of the tumor microenvironment after magnetic-assisted tumor </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-04T08:36:40.047Z</modification><creation>2024-11-21T02:48:46.574Z</creation></dates><accession>S-EPMC9043768</accession><cross_references><pubmed>35496387</pubmed><doi>10.1039/d1ra04975e</doi></cross_references></HashMap>